SPONSOR
Max-Planck-Institute of Psychiatry
Total Trials
1
Recruiting
1
Phases
N/A
Max-Planck-Institute of Psychiatry is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Depressive Disorder, Post-Acute COVID-19 Syndrome.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Max-Planck-Institute of Psychiatry
How many clinical trials has Max-Planck-Institute of Psychiatry sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Max-Planck-Institute of Psychiatry, of which 1 are actively recruiting participants. These trials cover conditions including Depressive Disorder, Post-Acute COVID-19 Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Max-Planck-Institute of Psychiatry research focus on?
Max-Planck-Institute of Psychiatry clinical trials span Depressive Disorder, Post-Acute COVID-19 Syndrome. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Max-Planck-Institute of Psychiatry clinical trial?
To participate in a Max-Planck-Institute of Psychiatry trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Max-Planck-Institute of Psychiatry trials with current recruitment status updated daily.
Clinical Trials by Max-Planck-Institute of Psychiatry
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology